Allspring Global Investments Holdings LLC Cuts Position in UnitedHealth Group Incorporated (NYSE:UNH)

Allspring Global Investments Holdings LLC trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 8.1% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 358,737 shares of the healthcare conglomerate’s stock after selling 31,410 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in UnitedHealth Group were worth $181,012,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of UNH. M&T Bank Corp lifted its holdings in shares of UnitedHealth Group by 13.4% during the 3rd quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock valued at $128,975,000 after purchasing an additional 26,074 shares during the last quarter. Sugarloaf Wealth Management LLC grew its stake in shares of UnitedHealth Group by 17.6% during the fourth quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock worth $4,025,000 after acquiring an additional 1,193 shares during the last quarter. Benjamin Edwards Inc. raised its position in shares of UnitedHealth Group by 1,275.3% in the 3rd quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock valued at $26,060,000 after purchasing an additional 41,308 shares during the last quarter. Parsifal Capital Management LP acquired a new position in UnitedHealth Group during the 3rd quarter valued at approximately $21,165,000. Finally, Signal Advisors Wealth LLC grew its holdings in shares of UnitedHealth Group by 13.0% during the fourth quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock valued at $4,611,000 after buying an additional 1,051 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 0.1 %

NYSE:UNH opened at $533.99 on Wednesday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a market cap of $491.42 billion, a PE ratio of 34.45, a price-to-earnings-growth ratio of 1.45 and a beta of 0.61. The stock has a fifty day moving average price of $527.67 and a 200 day moving average price of $564.22. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter in the previous year, the firm earned $5.83 earnings per share. The firm’s quarterly revenue was up 6.8% on a year-over-year basis. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction on Friday, January 17th. The stock was bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 0.33% of the company’s stock.

Analyst Ratings Changes

Several analysts have weighed in on UNH shares. Cantor Fitzgerald reiterated an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. Truist Financial reduced their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Stephens raised their target price on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. Barclays reduced their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research note on Friday, January 17th. Finally, Oppenheimer raised their target price on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. One investment analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.